readthroughSign in
CompanyPMNNasdaqToronto, A6

ProMis Neurosciences, Inc

ProMIS Neurosciences develops therapeutic antibodies and vaccines targeting toxic oligomers in neurodegenerative diseases.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 12Latest story